Old and new findings on lipopolysaccharide-binding protein: a soluble pattern-recognition molecule
- PMID: 21787335
- DOI: 10.1042/BST0390989
Old and new findings on lipopolysaccharide-binding protein: a soluble pattern-recognition molecule
Abstract
LBP [LPS (lipopolysaccharide)-binding protein] was discovered approximately 25 years ago. Since then, substantial progress has been made towards our understanding of its function in health and disease. Furthermore, the discovery of a large protein family sharing functional and structural attributes has helped in our knowledge. Still, key questions are unresolved, and here an overview on the old and new findings on LBP is given. LBP is an acute-phase protein of the liver, but is also synthesized in other cells of the organism. While LBP is named after the ability to bind to LPS of Gram-negative bacteria, it also can recognize other bacterial compounds, such as lipopeptides. It has been shown that LBP is needed to combat infections; however, the main mechanism of action is still not clear. New findings on natural genetic variations of LBP leading to functional consequences may help in further elucidating the mechanism of LBP and its role in innate immunity and disease.
Similar articles
-
Non-LPS targets and actions of LPS binding protein (LBP).J Endotoxin Res. 2005;11(4):237-42. doi: 10.1179/096805105X37420. J Endotoxin Res. 2005. PMID: 16176661 Review.
-
The localization of two mimic epitopes of lipopolysaccharide binding protein and the preparation of their tandem multiple antigen peptide.J Immunol Methods. 2010 Oct 31;362(1-2):60-9. doi: 10.1016/j.jim.2010.09.003. Epub 2010 Sep 15. J Immunol Methods. 2010. PMID: 20833181
-
The role of lipopolysaccharide-binding protein in modulating the innate immune response.Microbes Infect. 2006 Mar;8(3):946-52. doi: 10.1016/j.micinf.2005.10.006. Epub 2006 Jan 13. Microbes Infect. 2006. PMID: 16483818 Review.
-
The crystal structure of lipopolysaccharide binding protein reveals the location of a frequent mutation that impairs innate immunity.Immunity. 2013 Oct 17;39(4):647-60. doi: 10.1016/j.immuni.2013.09.005. Epub 2013 Oct 10. Immunity. 2013. PMID: 24120359
-
Gene therapy with lipopolysaccharide binding protein for gram-negative pneumonia: respiratory physiology.J Trauma. 2006 Sep;61(3):598-605; discussion 605-6. doi: 10.1097/01.ta.0000233763.18853.5b. J Trauma. 2006. PMID: 16966994
Cited by
-
Immunopharmacology of lipid A mimetics.Adv Pharmacol. 2013;66:81-128. doi: 10.1016/B978-0-12-404717-4.00003-2. Adv Pharmacol. 2013. PMID: 23433456 Free PMC article. Review.
-
TRAF3-interacting JNK-activating modulator promotes inflammation by stimulating translocation of Toll-like receptor 4 to lipid rafts.J Biol Chem. 2019 Feb 22;294(8):2744-2756. doi: 10.1074/jbc.RA118.003137. Epub 2018 Dec 20. J Biol Chem. 2019. PMID: 30573680 Free PMC article.
-
3LPS-binding protein and its interactions with P. gingivalis LPS modulate pro-inflammatory response and Toll-like receptor signaling in human oral keratinocytes.PLoS One. 2017 Apr 6;12(4):e0173223. doi: 10.1371/journal.pone.0173223. eCollection 2017. PLoS One. 2017. PMID: 28384159 Free PMC article.
-
Biomarkers of inflammation - LBP and TLR- predict progression of knee osteoarthritis in the DOXY clinical trial.Osteoarthritis Cartilage. 2018 Dec;26(12):1658-1665. doi: 10.1016/j.joca.2018.08.005. Epub 2018 Aug 23. Osteoarthritis Cartilage. 2018. PMID: 30144513 Free PMC article. Clinical Trial.
-
A Comparative Review of Equine SIRS, Sepsis, and Neutrophils.Front Vet Sci. 2019 Mar 12;6:69. doi: 10.3389/fvets.2019.00069. eCollection 2019. Front Vet Sci. 2019. PMID: 30931316 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous